Parliamentary.ai


by Munro Research

Medical Cannabis (Access) Bill


Official Summary

A Bill to make provision about access to cannabis for medical reasons; and for connected purposes.

Summary powered by AnyModel

Overview

This bill aims to improve access to medical cannabis in England. It proposes creating a register of GPs allowed to prescribe cannabis and establishes a commission to review the current system and recommend improvements to access.

Description

The bill makes two key changes. Firstly, it amends the Medical Act 1983 to allow the General Medical Council (GMC) to create a register of GPs who are trained and willing to prescribe cannabis-based products. GP participation would be voluntary. Secondly, it amends the Misuse of Drugs Regulations 2001 to permit registered GPs to prescribe cannabis.

Commission on Cannabis-Based Medicines

The bill also mandates the creation of a commission to examine and propose a framework for assessing cannabis-based medicines for prescription. This commission will consult widely, including with relevant experts, patients, and organizations, and will provide a report to the Secretary of State within six months of its establishment. The commission's recommendations will focus on improving access to cannabis-based medicines through the National Health Service (NHS).

Government Spending

The bill doesn't specify any direct government spending figures. However, the establishment of the commission and potential changes to NHS prescribing practices could lead to increased costs or savings depending on the commission's recommendations.

Groups Affected

  • General Practitioners (GPs): GPs will have the option to register with the GMC to prescribe cannabis, potentially increasing their workload and requiring additional training.
  • Patients: Patients with conditions that might benefit from cannabis-based medicines could see improved access to treatment, provided their GP is registered and willing to prescribe.
  • The NHS: The NHS will be affected by the changes in prescribing practices and may experience increased demand for cannabis-based medications.
  • Pharmaceutical Companies: Companies producing and supplying cannabis-based medicines could see increased demand for their products.
  • The General Medical Council (GMC): The GMC will be responsible for managing the register of GPs who can prescribe cannabis.
Full Text

Powered by nyModel

DISCLAIMER: AI technology is not 100% accurate and summaries may contain errors, use at your own risk. Munro Research holds the copyright for all summaries found this website. Reproduction for non-commercial purposes is permitted but must be displayed alongside a link to this website. Contact info@munro-research to license commercially.